Literature DB >> 6263290

Effect of high-dose methylprednisolone infusion on polymorphonuclear leukocyte function in patients with systemic lupus erythematosus.

H D Perez, R P Kimberley, H B Kaplan, H Edelson, R D Inman, I M Goldstein.   

Abstract

We have studied the effect of high-dose (1 gm) methylprednisolone infusion on polymorphonuclear leukocyte (PMN) function in 11 patients with active systemic lupus erythematosus (SLE). The only alteration of polymorphonuclear leukocyte function produced consistently by methylprednisolone was decreased adherence to plastic surfaces when tested 2 hours after infusion. This steroid-induced abnormality, however, was transient. Cells obtained from patients 24 hours after a single dose of drug exhibited normal adhesiveness. These results indicate that single, large doses of methylprednisolone do not produce long-lasting abnormalities of PMN function in patients with lupus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6263290     DOI: 10.1002/art.1780240502

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  3 in total

1.  Polymorphonuclear leucocyte motility in men with ankylosing spondylitis.

Authors:  C T Pease; M Fennell; D A Brewerton
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

2.  Effect of high-dose methylprednisolone therapy on phagocyte function in systemic lupus erythematosus.

Authors:  S H Boghossian; D A Isenberg; G Wright; M L Snaith; A W Segal
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

3.  Combination of methylprednisolone pulse therapy and remission inducing drugs in rheumatoid arthritis.

Authors:  T M Hansen; E Dickmeiss; H Jans; T Ingemann Hansen; M Ingeman-Nielsen; I Lorenzen
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.